Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-09-11FDA Approved: ESCITALOPRAM — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic escitalopram (escitalopram) under an Original Application, for its approved indications in major…
-
FDA approval · 2012-09-11FDA Approved: ESCITALOPRAM — Original Application (Rising Pharma Holdings, Inc.)
FDA approves an original-application ANDA for escitalopram from Rising Pharma Holdings, enabling a generic version of the antidepressant. Th…
-
FDA approval · 2012-09-11FDA Approved: ESCITALOPRAM OXALATE — Original Application (Exelan Pharmaceuticals Inc.)
FDA approved the original application for escitalopram oxalate as a generic product, manufactured by Exelan Pharmaceuticals Inc., to treat m…
-
FDA approval · 2012-09-11FDA Approved: ESCITALOPRAM — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for escitalopram oxalate by Aurobindo Pharma Limited, enabling a generic version of escitalopram. The …
-
FDA approval · 2012-08-02FDA Approved: WELLBUTRIN XL — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for Wellbutrin XL (bupropion hydrochloride) from Bausch Health US LLC, likely resulting in a lab…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-08-02FDA Approved: WELLBUTRIN SR — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for WELLBUTRIN SR (bupropion hydrochloride) submitted by GlaxoSmithKline LLC.
-
FDA approval · 2012-07-31FDA Approved: FLUOXETINE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for fluoxetine hydrochloride from PAI Holdings (PAI Pharma), confirming approval of a generic fluoxe…
-
FDA approval · 2012-07-31FDA Approved: VENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for venlafaxine by Alembic Pharmaceuticals Inc. to support a generic version of the antidepressant. …
-
FDA approval · 2012-07-31FDA Approved: PAROXETINE — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for a generic paroxetine hydrochloride product submitted by NorthStar Rx LLC.
-
FDA approval · 2012-07-31FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application for paroxetine hydrochloride from Zydus Lifesciences Limited, authorizing its marketing as a gen…
-
FDA approval · 2012-06-26FDA Approved: CITALOPRAM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's supplemental application for citalopram under an ANDA, confirming approval of a generic cital…
-
FDA approval · 2012-06-26FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical’s supplemental application for venlafaxine hydrochloride, a generic product. The approval relates to the sta…
-
FDA approval · 2012-06-19FDA Approved: OLANZAPINE AND FLUOXETINE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved the original application for a fixed-dose combination of olanzapine and fluoxetine (olanzapine/fluoxetine) by Teva Pharmaceutic…
-
FDA approval · 2012-06-12FDA Approved: ESCITALOPRAM OXALATE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original ANDA for escitalopram oxalate, a generic version of the antidepressant, for treating major dep…
-
FDA approval · 2012-05-29FDA Approved: CITALOPRAM HYDROBROMIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for a generic citalopram hydrobromide product manufactured by Aurobindo Pharma Limited.
-
FDA approval · 2012-05-21FDA Approved: CITALOPRAM — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)
FDA approved a supplemental application for citalopram submitted by Chartwell Governmental & Specialty RX, LLC.
-
FDA approval · 2012-05-21FDA Approved: CITALOPRAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for citalopram by Hikma Pharmaceuticals USA Inc., authorizing the continued marketing of a generic c…
-
FDA approval · 2012-05-03FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) by Viatris Specialty LLC.
-
FDA approval · 2012-05-03FDA Approved: ESCITALOPRAM — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical's original application for escitalopram oxalate, a generic version of the antidepressant escitalopram.
-
FDA approval · 2012-05-02FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Vertical Pharmaceuticals, LLC)
The FDA approved a supplemental application for venlafaxine hydrochloride (Vertical Pharmaceuticals, LLC) to update the product labeling und…
-
FDA approval · 2012-04-25FDA Approved: CITALOPRAM — Supplemental Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s supplemental application for the generic antidepressant citalopram.
-
FDA approval · 2012-04-25FDA Approved: CITALOPRAM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approves Amneal Pharmaceuticals LLC's supplemental application for citalopram, a generic antidepressant, under the ANDA program.
-
FDA approval · 2012-04-25FDA Approved: CITALOPRAM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Citalopram hydrobromide by Aurobindo Pharma Limited. This constitutes a supplemental approval fo…
-
FDA approval · 2012-04-25FDA Approved: CITALOPRAM — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Citalopram from Mylan Pharmaceuticals Inc. The action relates to the generic product, approv…
-
FDA approval · 2012-04-23FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Actavis Pharma, Inc.)
FDA approves a supplemental application for Bupropion HCl sustained-release (Actavis), finalizing changes to the approved generic product.